Krónikus obstruktív tüdőbetegség (COPD): vizsgálatok itt: Dél-Korea
9 of 16 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleeValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- Where
- Daegu, Incheon, Jeonju, Seongnam-si Gyeonggi-do, Seoul
- Életkor
- 40 év to 75 év
- People
- 1196 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07177339 · EU 2025-521108-23-00 - 2. fázisNot yet taking people in Dél-KoreaA Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Where
- Bupyeong-gu, Dongjak-gu, Gyeongsan-si, Seoul, Ulsan, Wŏnju
- Életkor
- 40 év to 75 év
- People
- 606 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07759245 · EU 2026-525480-41-00 - 2. fázisTaking peopleA Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Where
- Anyang-si, Cheongju-si, Chuncheon, Daegu, Jeonju, Seongnam-si, Seoul, Wŏnju
- Életkor
- 40 év and over
- People
- 987 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07082738 - 3. fázisTaking peopleEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Where
- Anyang-si, Daegu, Jeonju, Seoul
- Életkor
- 40 év to 80 év
- People
- 942 worldwide
- Run by
- Sanofi
See details and how to joinNCT07190222 · EU 2024-518213-25-00 - 2/3. fázisTaking peopleA Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Where
- Jeonju, Seoul
- Életkor
- 35 év to 80 év
- People
- 1156 worldwide
- Run by
- Pfizer
See details and how to joinNCT07363694 · EU 2024-518587-12-00 - 4. fázisTaking peopleA Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- Where
- Anyang-si, Seoul
- Életkor
- 40 év to 85 év
- People
- 218 worldwide
- Run by
- Sanofi
See details and how to joinNCT07053423 - 3. fázisTaking peopleDepemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- Where
- Daegu, Incheon, Jeonju, Seoul
- Életkor
- 40 év to 80 év
- People
- 961 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06961214 · EU 2024-520417-41-00 - 3. fázisTaking peopleA Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Where
- Anyang-si, Busan, Daegu, Gwangju, Jeonju, Seoul, Uijeongbu-si, Ulsan
- Életkor
- 40 év to 80 év
- People
- 5250 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Where
- Anyang-si, Daegu, Iksan-si, Jeonju, Seoul, Uijeongbu-si, Wŏnju
- Életkor
- 40 év to 80 év
- People
- 990 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06883305 · EU 2024-517458-90-00